WU-NK-101 (W-NK), a Memory-like (ML) NK Cell, Intrinsically Overcomes Factors Restricting Adoptive Cell Therapy (ACT) in Acute Myeloid Leukemia (AML)

被引：1
|
作者：
Rutella, Sergio [1 ]
Muth, John [2 ]
Vadakekolathu, Jayakumar [1 ]
Leedom, Tom [3 ]
Hamil, Alex [3 ]
Arthur, Laura [2 ]
Mahajan, Nitin [2 ]
Schramm, Elizabeth [2 ]
Warin, Renaud [4 ]
Foust, Amber M. [5 ]
Boocock, David [6 ]
Coveney, Clare [6 ]
Baughman, Jan [7 ]
Petit, Vincent [8 ]
Bhatnagar, Nupur [9 ]
Magee, Kristann [2 ]
Berrien-Elliott, Melissa M. [10 ]
Cooper, Matthew L. [2 ]
Davidson-Moncada, Jan [11 ]
Fehniger, Todd A. [10 ]
机构：
[1] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England
[2] Wugen, St Louis, MO USA
[3] Wugen, San Diego, CA USA
[4] Carolina BioOncol, Huntersville, NC USA
[5] Carolina BioOncol, Hunterville, NC USA
[6] Nottingham Trent Univ, Nottingham, England
[7] Alviso Clin Res, San Francisco, CA USA
[8] Metafora Biosyst, Paris, France
[9] Inst Pasteur, Paris, France
[10] Washington Univ, Sch Med, St Louis, MO USA
[11] Wugen, Washington, DC USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184923
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 17 条
  • [1] WU-NK-101 (W-NK), a Memory-like (ML) NK Cell, Naturally Overcomes Tumor Microenvironment (TME) Metabolic Challenges, Retaining Anti-Tumor Potency
    Bhatnagar, Nupur
    Petit, Vincent
    Vadakekolathu, Jayakumar
    Pinset, Christian
    Mahajan, Nitin
    Dean, John
    Spingola, Christine
    Arthur, Laura
    Boocock, David
    Coveney, Clare
    Muth, John
    Baughman, Jan
    Berrien-Elliott, Melissa M.
    Sitbon, Marc
    Cooper, Matthew L.
    Davidson-Moncada, Jan
    Fehniger, Todd A.
    Rutella, Sergio
    BLOOD, 2023, 142
  • [2] Putative Predictors of Response to WU-NK-101, an Allogeneic, Enhanced Memory (ML) Natural Killer (NK) Cell Therapy Product, for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
    Rutella, Sergio
    Cashen, Amanda F.
    Muth, John
    Mathyer, Mary Elizabeth
    Carter, Alun James
    Tumala, Brunda
    Arthur, Laura
    Magee, Kristann
    Comune Pennacchi, Paula
    Gorrochategui, Julian
    Petit, Vincent
    Primo, Daniel
    Blanchard, Dominique
    Kiebish, Michael
    Bhatnagar, Nupur
    Boocock, David
    Vadakekolathu, Jayakumar
    Cooper, Matthew L.
    Berrien-Elliott, Melissa M.
    Davidson-Moncada, Jan K.
    Fehniger, Todd A.
    BLOOD, 2022, 140 : 7400 - 7401
  • [3] WU-NK-101, best in class memory-NK cell, has key features vital for adoptive cell therapy (ACT) in solid tumors (ST)
    Muth, J.
    Leedom, T.
    Magee, K.
    Muz, B.
    Vadakekulathu, J.
    Petit, V.
    Bhatnagar, N.
    Primo, D.
    Pennacchi, P. Comune
    Berrien-Elliott, M.
    Fehniger, T. A.
    Davidson-Moncada, J.
    Rutella, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1173 - S1173
  • [4] A Phase 1 Study of WU-NK-101 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
    Cashen, Amanda F.
    Liu, Hongtao
    Al Malki, Monzr M.
    Zeidner, Joshua F.
    Foster, Matthew C.
    Pannunzio, Angela
    Ramsey, Brett
    Baughman, Jan
    Muth, John
    Bakkacha, Ouiam
    McNulty, Eileen
    Jacobs, Kenneth
    Davidson-Moncada, Jan K.
    Wei, Andrew H.
    BLOOD, 2022, 140 : 12740 - 12741
  • [5] WU-NK-101, an enhanced memory natural killer (NK) cell therapy, with cetuximab (Ctx) for the treatment of advanced colorectal cancer (CRC).
    Muth, John
    Leedom, Tom
    Hamil, Alexander
    Luukkonen, Lena
    Tumala, Brunda
    Carter, Alun
    Magee, Kristann
    Pennacchi, Paula Comune
    Primo, Daniel
    Kiebish, Michael A.
    Boocock, David
    Vadakekolathu, Jayakumar
    Petit, Vincent
    Baughman, Jan E.
    Bhatnagar, Nupur
    Cooper, Matthew
    Rutella, Sergio
    Berrien-Elliot, Melissa
    Davidson-Moncada, Jan
    Fehniger, Todd A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 170 - 170
  • [6] Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations
    Allan, David S. J.
    Wu, Chuanfeng
    Mortlock, Ryland D.
    Chakraborty, Mala
    Rezvani, Katayoun
    Davidson-Moncada, Jan K.
    Dunbar, Cynthia E.
    Childs, Richard W.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 28 : 74 - 87
  • [7] CYTOKINE INDUCED MEMORY-LIKE NK CELL THERAPY IN A PEDIATRIC PATIENT WITH RELAPSED AML AFTER SCT
    Zimmerman, Clare
    Bednarski, Jeffrey
    Fehniger, Todd
    Cashen, Amanda
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [8] Cytokine-Induced Memory-like (ML) NK Cells Persist for > 2 Months Following Adoptive Transfer into Leukemia Patients with a MHC-Compatible Hematopoietic Cell Transplant (HCT)
    Foltz, Jennifer A.
    Berrien-Elliott, Melissa M.
    Neal, Carly
    Foster, Mark
    McClain, Ethan
    Schappe, Tim
    Desai, Sweta
    Becker-Hapak, Michelle
    Cashen, Amanda F.
    Fehniger, Todd A.
    BLOOD, 2019, 134
  • [9] Human Cytokine-Induced Memory-like NK Cells Exhibit in Vivo Anti-Leukemia Activity in Xenografted NSG Mice and in Patients with Acute Myeloid Leukemia (AML)
    Romee, Rizwan
    Maximillian, Rosario
    Berrien-Elliott, Melissa M.
    Wagner, Julia A.
    Jewell, Brea A.
    Schappe, Timothy
    Leong, Jeffrey W.
    Schneider, Stephanie E.
    Willey, Sarah
    Fehniger, Todd A.
    BLOOD, 2015, 126 (23)
  • [10] Combining Cytokine-Induced Memory-like NK Cells with Tafasitamab Demonstrates Efficacy Against Acute B-Cell Leukemia
    Filioglou, Dimitrios
    Leite, Geovana S. F.
    Batatinha, Helena
    Santa-Cruz, Nina
    Simpson, Richard
    Katsanis, Emmanuel
    BLOOD, 2024, 144 : 5906 - 5907
12